Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Sosnowiec
Clinical trial register · Poland

Clinical Trials in Sosnowiec, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 1315 Krakow 882 Poznan 705 Gdansk 657 Lodz 619
Narrow the registerReset
Recruitment status
Phase
Site location
Warsaw1315 Krakow882 Poznan705 Gdansk657 Lodz619
All 264 locations
Target enrolment
to

Trials with a site in Sosnowiec

27 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
NCT06968845Idiopathic Pulmonary Fibrosis (IPF)
Rein Therapeutics
Phase 2
120
Nowa Sól, Lodz, Rzeszów, Warsaw, Sosnowiec
2026-02-02
Recruiting
Kymera Therapeutics, Inc.
Phase 2
264
Bialystok, Gdansk, Lodz, Poznan, Sosnowiec, Tarnów, Trzebnica, Wroclaw
2026-01-28
Recruiting
Contineum Therapeutics
Phase 2
324
Bydgoszcz, Świdnik, Bialystok, Sosnowiec
2026-01-08
Active, closed
UCB Biopharma SRL
Phase 2
165
Chorzów, Katowice, Krakow, Lodz, Sosnowiec, Tarnów, Warsaw, Wroclaw
2025-12-29
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
450
Bydgoszcz, Koszalin, Krakow, Skórzewo, Sosnowiec, Warsaw, Wrocaw
2025-12-12
Active, closed
Pfizer
Phase 2
128
Wroclaw, Gdansk, Ostrowiec Świętokrzyski, Rzeszów, Sosnowiec, Szczecin, Warsaw
2025-11-13
Recruiting
GlaxoSmithKline
Phase 2
363
Bialystok, Ksawerów, Piaseczno, Rzeszów, Sosnowiec
2025-10-30
Recruiting
Sanofi
Phase 3
942
Wroclaw, Piaseczno, Bialystok, Katowice, Elblag, Sosnowiec
2025-09-16
Active, closed
Triveni Bio
Phase 2
95
Wroclaw, Warsaw, Chorzów, Katowice, Poznan, Sosnowiec
2025-08-26
Recruiting
Bristol-Myers Squibb
Phase 3
274
Poznan, Warsaw, Bialystok, Gdansk, Rybnik, Sosnowiec, Tuszyn
2025-06-11
Recruiting
Pfizer
Phase 2
252
Poznan, Krakow, Tarnów, Wroclaw, Bychawa, Sosnowiec
2025-05-20
Recruiting
Apogee Therapeutics, Inc.
Phase 2
350
Wroclaw, Lublin, Warsaw, Gdansk, Katowice, Sosnowiec, Szczecin, Krakow
2025-05-14
Recruiting
Pfizer
Phase 3
674
Poznan, Krakow, Wroclaw, Lublin, Nowa Sól, Warsaw, Katowice, Sosnowiec
2025-04-01
Recruiting
Comparing the Safety and Effectiveness of Different Doses of Morphine Administered in Spinal Anethesia for Pain Relief After Hip Replacement Surgery
NCT06878014Analgesics, Opioid, Anesthesia, Spinal, Total Hip Replacement, Adverse Anesthesia Outcome
Medical University of Silesia
Phase 4
120
Sosnowiec, Szczecin, Gmina Końskie
2025-03-04
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
Janssen Research & Development, LLC
Phase 3
196
Rzeszów, Sosnowiec, Warsaw
2024-10-29
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Amgen
Phase 3
163
Bydgoszcz, Lublin, Olsztyn, Krakow, Przemyśl, Sosnowiec
2024-09-12
Active, closed
A Study Evaluating APG777 in Atopic Dermatitis
NCT06395948Atopic Dermatitis
DrugAPG777
Apogee Therapeutics, Inc.
Phase 2
470
Wroclaw, Lublin, Warsaw, Gdansk, Katowice, Sosnowiec, Szczecin, Krakow
2024-04-29
Recruiting
Swiss GO Trial Group
Observational
1,000
Sosnowiec
2024-03-15
Active, closed
AstraZeneca
Phase 3
314
Bydgoszcz, Krakow, Lodz, Sosnowiec, Warsaw
2023-11-08
Recruiting
Ipsen
Phase 3
276
Elblag, Katowice, Krakow, Lodz, Lublin, Małogoskie, Rzeszów, Sosnowiec
2023-08-31
Active, closed
Alumis Inc
Phase 2
408
Bytom, Bialystok, Bydgoszcz, Częstochowa, Krakow, Nadarzyn, Poznan, Sosnowiec
2023-06-26
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Nowy Targ, Ostrołęka, Sosnowiec, Bialystok, Bydgoszcz, Gdansk, Gdynia, Kielce
2021-11-23
Active, closed
A Long-term Extension Study of Ustekinumab in Pediatric Participants
NCT05092269Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic
Janssen Research & Development, LLC
Phase 3
159
Krakow, Rzeszów, Sosnowiec, Torun, Warsaw
2021-10-18
Active, closed
Sun Pharmaceutical Industries Limited
Phase 2/3
135
Bialystok, Katowice, Lodz, Lublin, Ostrowiec Świętokrzyski, Sosnowiec, Szczecin, Warsaw
2020-01-15
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/sosnowiec

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies with a site in Sosnowiec.

How many clinical trials are recruiting in Sosnowiec?

17 of the 27 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Sosnowiec), 27 studies
PhaseStudiesRecruitingShare
Phase 312844.4%
Phase 211640.7%
Phase 2/3217.4%
Observational113.7%
Phase 4113.7%

Most active sponsors

Lead sponsors with the most studies (Sosnowiec)
Lead sponsorStudiesRecruiting
Pfizer32
AbbVie22
Apogee Therapeutics, Inc.21
Janssen Research & Development, LLC21
UCB Biopharma SRL21
Alumis Inc10
Amgen10
AstraZeneca10
Bristol-Myers Squibb11
Contineum Therapeutics11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.